BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

345 related articles for article (PubMed ID: 25860984)

  • 1. Routine use of recombinant human bone morphogenetic protein-2 in posterior fusions of the pediatric spine and incidence of cancer.
    Sayama C; Willsey M; Chintagumpala M; Brayton A; Briceño V; Ryan SL; Luerssen TG; Hwang SW; Jea A
    J Neurosurg Pediatr; 2015 Jul; 16(1):4-13. PubMed ID: 25860984
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The efficacy of routine use of recombinant human bone morphogenetic protein-2 in occipitocervical and atlantoaxial fusions of the pediatric spine: a minimum of 12 months' follow-up with computed tomography.
    Sayama C; Hadley C; Monaco GN; Sen A; Brayton A; Briceño V; Tran BH; Ryan SL; Luerssen TG; Fulkerson D; Jea A
    J Neurosurg Pediatr; 2015 Jul; 16(1):14-20. PubMed ID: 25860982
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Routine use of recombinant human bone morphogenetic protein-2 in posterior fusions of the pediatric spine: safety profile and efficacy in the early postoperative period.
    Fahim DK; Whitehead WE; Curry DJ; Dauser RC; Luerssen TG; Jea A
    Neurosurgery; 2010 Nov; 67(5):1195-204; discussion 1204. PubMed ID: 20871458
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Safety, efficacy, and dosing of recombinant human bone morphogenetic protein-2 for posterior cervical and cervicothoracic instrumented fusion with a minimum 2-year follow-up.
    Hamilton DK; Smith JS; Reames DL; Williams BJ; Chernavvsky DR; Shaffrey CI
    Neurosurgery; 2011 Jul; 69(1):103-11; discussion 111. PubMed ID: 21368688
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Perioperative complications of recombinant human bone morphogenetic protein-2 on an absorbable collagen sponge versus iliac crest bone graft for posterior cervical arthrodesis.
    Crawford CH; Carreon LY; McGinnis MD; Campbell MJ; Glassman SD
    Spine (Phila Pa 1976); 2009 Jun; 34(13):1390-4. PubMed ID: 19440166
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Multilevel anterior cervical discectomy and fusion with and without rhBMP-2: a comparison of dysphagia rates and outcomes in 150 patients.
    Lu DC; Tumialán LM; Chou D
    J Neurosurg Spine; 2013 Jan; 18(1):43-9. PubMed ID: 23157278
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Transforaminal lumbar interbody fusion with rhBMP-2 in spinal deformity, spondylolisthesis, and degenerative disease--part 2: BMP dosage-related complications and long-term outcomes in 509 patients.
    Crandall DG; Revella J; Patterson J; Huish E; Chang M; McLemore R
    Spine (Phila Pa 1976); 2013 Jun; 38(13):1137-45. PubMed ID: 23354111
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Complications associated with recombinant human bone morphogenetic protein use in pediatric craniocervical arthrodesis.
    Lindley TE; Dahdaleh NS; Menezes AH; Abode-Iyamah KO
    J Neurosurg Pediatr; 2011 May; 7(5):468-74. PubMed ID: 21529186
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Transforaminal lumbar interbody fusion with rhBMP-2 in spinal deformity, spondylolisthesis, and degenerative disease--part 1: Large series diagnosis related outcomes and complications with 2- to 9-year follow-up.
    Crandall DG; Revella J; Patterson J; Huish E; Chang M; McLemore R
    Spine (Phila Pa 1976); 2013 Jun; 38(13):1128-36. PubMed ID: 23370679
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The feasibility and safety of using sublaminar polyester bands in hybrid spinal constructs in children and transitional adults for neuromuscular scoliosis.
    Desai SK; Sayama C; Vener D; Brayton A; Briceño V; Luerssen TG; Jea A
    J Neurosurg Pediatr; 2015 Mar; 15(3):328-37. PubMed ID: 25555118
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Blood serum antibody analysis and long-term follow-up of patients treated with recombinant human bone morphogenetic protein-2 in the lumbar spine.
    Burkus JK; Gornet MF; Glassman SD; Slosar PJ; Rosner MK; Deckey JE; Nowak J; Hatcher BM
    Spine (Phila Pa 1976); 2011 Dec; 36(25):2158-67. PubMed ID: 21325990
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Nationwide practice patterns in the use of recombinant human bone morphogenetic protein-2 in pediatric spine surgery as a function of patient-, hospital-, and procedure-related factors.
    Lam SK; Sayama C; Harris DA; Briceño V; Luerssen TG; Jea A
    J Neurosurg Pediatr; 2014 Nov; 14(5):476-85. PubMed ID: 25171721
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Complications in Adult Patients with Down Syndrome Undergoing Cervical Spine Surgery Using Current Instrumentation Techniques and rhBMP-2: A Long-Term Follow-Up.
    Siemionow K; Hansdorfer M; Janusz P; Mardjetko S
    J Neurol Surg A Cent Eur Neurosurg; 2017 Mar; 78(2):113-123. PubMed ID: 27448197
    [No Abstract]   [Full Text] [Related]  

  • 14. Comparison of transforaminal lumbar interbody fusion outcomes in patients receiving rhBMP-2 versus autograft.
    Khan TR; Pearce KR; McAnany SJ; Peters CM; Gupta MC; Zebala LP
    Spine J; 2018 Mar; 18(3):439-446. PubMed ID: 28822825
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Complications of rhBMP-2 utilization for posterolateral lumbar fusions requiring reoperation: a single practice, retrospective case series report.
    Hoffmann MF; Jones CB; Sietsema DL
    Spine J; 2013 Oct; 13(10):1244-52. PubMed ID: 23973099
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Nerve injury and recovery after lateral lumbar interbody fusion with and without bone morphogenetic protein-2 augmentation: a cohort-controlled study.
    Lykissas MG; Aichmair A; Sama AA; Hughes AP; Lebl DR; Cammisa FP; Girardi FP
    Spine J; 2014 Feb; 14(2):217-24. PubMed ID: 24269858
    [TBL] [Abstract][Full Text] [Related]  

  • 17. High-dose rhBMP-2 for adults: major and minor complications: a study of 502 spine cases.
    Mesfin A; Buchowski JM; Zebala LP; Bakhsh WR; Aronson AB; Fogelson JL; Hershman S; Kim HJ; Ahmad A; Bridwell KH
    J Bone Joint Surg Am; 2013 Sep; 95(17):1546-53. PubMed ID: 24005194
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Anterior lumbar interbody fusion using recombinant human bone morphogenetic protein-2: a prospective study of complications.
    Malham GM; Parker RM; Ellis NJ; Blecher CM; Chow FY; Claydon MH
    J Neurosurg Spine; 2014 Dec; 21(6):851-60. PubMed ID: 25279655
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Bone morphogenetic protein use in spine surgery in the United States: how have we responded to the warnings?
    Guzman JZ; Merrill RK; Kim JS; Overley SC; Dowdell JE; Somani S; Hecht AC; Cho SK; Qureshi SA
    Spine J; 2017 Sep; 17(9):1247-1254. PubMed ID: 28456674
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Urological complications following use of recombinant human bone morphogenetic protein-2 in anterior lumbar interbody fusion: presented at the 2012 Joint Spine Section Meeting: clinical article.
    Lubelski D; Abdullah KG; Nowacki AS; Alvin MD; Steinmetz MP; Chakka S; Li Y; Gajewski N; Benzel EC; Mroz TE
    J Neurosurg Spine; 2013 Feb; 18(2):126-31. PubMed ID: 23231356
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 18.